Smith & Nephew (SNN) EPS (Weighted Average and Diluted) Growth (1y) (2010 - 2024)
Smith & Nephew (SNN) EPS (Weighted Average and Diluted) Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -19.74% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 14.20% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -11.88% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 100.00% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 8.20% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 88.89% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -30.89% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 47.37% |
| 10 | Smith & Nephew | 5.27 Bn | 4.69 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 128.74% |
| Dec 31, 2016 | 34.87% |
| Dec 31, 2015 | -51.12% |
| Dec 31, 2014 | 454.95% |
| Mar 31, 2014 | -7.59% |
| Mar 31, 2013 | -9.84% |
| Jun 30, 2012 | 25.35% |
| Mar 31, 2012 | 13.30% |
| Dec 31, 2011 | -390.27% |
| Sep 30, 2011 | 92,206,881.29% |
| Jun 30, 2011 | 197.72% |
| Mar 31, 2011 | -24.69% |
| Dec 31, 2010 | 23.45% |
| Sep 30, 2010 | -7.43% |
| Jun 30, 2010 | -8.35% |
| Mar 31, 2010 | 38.81% |